Conservative and timely treatment in retained products of conception: a case report of placenta accreta ritention

Journal List Int J Clin Exp Pathol v.8(10); 2015 PMC4680531 As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with, the contents by NLM or the National Institutes of Health. Learn more: PMC Disclaimer | PMC Copyright Notice Int J Clin Exp Pathol. 2015; 8(10): 13625–13629. Published online 2015 Oct 1. PMCID: PMC4680531PMID: 26722586Guarino Antonella, Di Benedetto Luisa, Assorgi Chiara, Rocca Alessandra, Donatella CasertaAuthor information Article notes Copyright and License information PMC DisclaimerAbstractThe term retained products of conception (RPOC) refers to intrauterine tissue that develops after conception and persists after medical and surgical pregnancy termination, miscarriage, and vaginal or cesarean delivery. One of the most important factor risk for RPOC is placenta accreta, defined as “the abnormal adherence, either in whole or in part, of the afterbirth to the underlying uterine wall”. We...